Literature DB >> 6442397

Glycine potentiates the action of some anticonvulsant drugs in some seizure models.

E Toth, A Lajtha.   

Abstract

The anticonvulsant effect of either phenobarbital or dilantin was potentiated by exogenous glycine in DBA/2 audiogenic seizure mice and in 3-mercaptopropionic acid-induced seizures. In seizures caused by pentylenetetrazol, glycine potentiated the anticonvulsant effect of phenobarbital only slightly; in combination with dilantin, which was ineffective by itself, it did not have an effect. Valproic acid, in large doses, prevented 3-mercaptopropionic acid-induced seizures; glycine did not potentiate its effect. Glycine thus potentiates anticonvulsant effects, but only of some drugs and only in some of the seizure models. This suggests that the mechanism of the anticonvulsant effect of glycine is similar to that of some of the anticonvulsant drugs such as dilantin and different from others, and that this mechanism is not effective in all seizure models.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6442397     DOI: 10.1007/bf00968081

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

Review 1.  Epilepsy and gamma-aminobutyric acid-mediated inhibition.

Authors:  B S Meldrum
Journal:  Int Rev Neurobiol       Date:  1975       Impact factor: 3.230

2.  Different actions of anticonvulsant and anesthetic barbiturates revealed by use of cultured mammalian neurons.

Authors:  R L Macdonald; J L Barker
Journal:  Science       Date:  1978-05-19       Impact factor: 47.728

3.  Uptake and binding of catecholamines. Effect of diphenylhydantoin and a new mechanism of action.

Authors:  M G Hadfield
Journal:  Arch Neurol       Date:  1972-01

4.  The effect of diphenylhydantoin administration on sodium-potassium-activated ATPase in cortex.

Authors:  E Lewin; V Bleck
Journal:  Neurology       Date:  1971-06       Impact factor: 9.910

5.  Effect of anticonvulsants on brain serotonin.

Authors:  T N Chase; R I Katz; I J Kopin
Journal:  Trans Am Neurol Assoc       Date:  1969

Review 6.  On the sacred disease: the neurochemistry of epilepsy.

Authors:  O C Snead
Journal:  Int Rev Neurobiol       Date:  1983       Impact factor: 3.230

7.  The effects of anaesthetic and convulsant barbiturates on the efflux of [3H]D-aspartate from brain minislices.

Authors:  M Willow; J C Bornstein; G A Johnston
Journal:  Neurosci Lett       Date:  1980-06       Impact factor: 3.046

8.  Anticonvulsant drug mechanisms. Phenytoin, phenobarbital, and ethosuximide and calcium flux in isolated presynaptic endings.

Authors:  R S Sohn; J A Ferrendelli
Journal:  Arch Neurol       Date:  1976-09

9.  Acute effects of sodium valproate and gamma-vinyl GABA on regional amino acid metabolism in the rat brain: incorporation of 2-[14C]glucose into amino acids.

Authors:  A G Chapman; K Riley; M C Evans; B S Meldrum
Journal:  Neurochem Res       Date:  1982-09       Impact factor: 3.996

10.  Changes in regional brain levels of amino acid putative neurotransmitters after prolonged treatment with the anticonvulsant drugs diphenylhydantoin, phenobarbitone, sodium valproate, ethosuximide, and sulthiame in the rat.

Authors:  P N Patsalos; P T Lascelles
Journal:  J Neurochem       Date:  1981-02       Impact factor: 5.372

View more
  3 in total

1.  A glycinergic intervention potentiates the antiseizure efficacies of MK-801, flurazepam, and carbamazepine.

Authors:  D O Norris; J Mastropaolo; D A O'Connor; J M Cohen; S I Deutsch
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

2.  Comparative pharmacokinetic and pharmacodynamic analysis of phthaloyl glycine derivatives with potential antiepileptic activity.

Authors:  O abu Salach; S Hadad; A Haj-Yehia; S Sussan; M Bialer
Journal:  Pharm Res       Date:  1994-10       Impact factor: 4.200

3.  Pharmacokinetic analysis and antiepileptic activity of N-valproyl derivatives of GABA and glycine.

Authors:  S Hadad; M Bialer
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.